Mergers & Acquisitions ·
Stereotaxis, Inc. completed its acquisition of Robocath, a French company, on July 7, 2026, for approximately $20…
STXSStereotaxis, Inc.
Stereotaxis, Inc. completed its acquisition of Robocath, a French company, on July 7, 2026, for approximately $20 million in cash and common stock. The transaction involved the issuance of 1,469,485 shares of common stock and 4,575,143 pre-funded warrants, alongside 225,000 shares issued to a financial advisor. Additional earnout performance targets could trigger up to $25.0 million in aggregate contingent consideration. Stereotaxis, Inc. is a medical technology company specializing in in vivo robotic magnetic navigation systems.